Zofran is a common drug prescribed “off-label” to women to treat nausea and vomiting during pregnancy. However, with studies linking the medication to birth defects, many families are now filing lawsuits against the manufacturer. If you or a loved one has been adversely affected by the drug Zofran, our expert personal injury lawyers in Miami at Goldberg & Rosen will help you recover the full and just compensation you deserve.
Manufactured by GlaxoSmithKline, Zofran is FDA-approved to treat nausea in cancer patients. It helps chemotherapy patients who vomit as a side effect of their treatment, as well as those who become sick after taking their medication. However, over time the manufacturer also began marketing the drug to pregnant women who suffered from morning sickness – despite the fact that the FDA never approved its use for these patients.
It’s estimated that as many as 80 percent of women suffer from nausea or vomiting during pregnancy. When it gets particularly severe, it can cause malnutrition and endanger both the mother and her unborn baby.
To treat this condition, physicians began prescribing Zofran. However, many babies born to mothers who took Zofran suffered severe birth defects such as:
- Heart defects
- Cleft lip
- Cleft palate
- Club foot
- Skull deformities
- Kidney defects
The increased risk for birth defects when pregnant women take Zofran is substantial. Some studies have found that Zofran during pregnancy doubles the risk of heart defects and leads to a 30% increased risk of birth defects overall.




